PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
21.69%
Net income growth under 50% of MCHP's 215.97%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
No Data
No Data available this quarter, please select a different quarter.
96.30%
Well above MCHP's 32.19% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
-28.00%
Both cut yoy SBC, with MCHP at -9.31%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
140.76%
Slight usage while MCHP is negative at -32.35%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
19.70%
AR growth while MCHP is negative at -16.66%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
137.50%
Some inventory rise while MCHP is negative at -95.02%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
291.67%
AP growth well above MCHP's 93.93%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
205.85%
Lower 'other working capital' growth vs. MCHP's 713.94%. David Dodd would see fewer unexpected short-term demands on cash.
-110.00%
Negative yoy while MCHP is 35.82%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
87.79%
Operating cash flow growth above 1.5x MCHP's 30.92%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-23.18%
Negative yoy CapEx while MCHP is 13.55%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
23.18%
Acquisition growth of 23.18% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-7.79%
Negative yoy purchasing while MCHP stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-27.27%
Both yoy lines are negative, with MCHP at -100.00%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
-32.87%
We reduce yoy other investing while MCHP is 104.59%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-6000.00%
Both yoy lines negative, with MCHP at -65.98%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
100.00%
Debt repayment similar to MCHP's 98.04%. Walter Schloss sees parallel liability management or similar free cash flow availability.
-9.52%
Both yoy lines negative, with MCHP at -83.47%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
No Data
No Data available this quarter, please select a different quarter.